UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035881
Receipt number R000040881
Scientific Title Effect of the test food on breath hydrogen excretion -A randomized, open-label, cross over study-
Date of disclosure of the study information 2019/02/15
Last modified on 2019/08/19 09:23:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of the test food on breath hydrogen excretion
-A randomized, open-label, cross over study-

Acronym

Effect of the test food on breath hydrogen excretion

Scientific Title

Effect of the test food on breath hydrogen excretion
-A randomized, open-label, cross over study-

Scientific Title:Acronym

Effect of the test food on breath hydrogen excretion

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of the test food on breath hydrogen excretion

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Breath hydrogen excretion(AUC 0-8h)

Key secondary outcomes

Breath hydrogen excretion(The observed values and the change from pre-intake of breath hydrogen excretion at each evaluation point)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Single intake of test food- single intake of control food

Interventions/Control_2

Single intake of control food- single intake of test food

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1)Male and Female aged from 20 to 65 years old at the time of informed consent is taken
2)Subjects whose BMI below 25 at the screening test
3)Subjects who eat 3 times a day
4)Subjects who agree to participate in the study on one's own will

Key exclusion criteria

1)Subjects who are suffering from disease affect gastric emptying and digestion function
2)Subjects who have a surgical history of the digestive organs
3)Subjects who have a disease such as upper respiratory inflammation and acute gastroenteritis
4)Subjects who defecate 3 times or above per day
5)Subjects who defecate less than 3 times per week
6)Subjects who are suffering from indigestion symptoms
7)Subjects who have a habit of excessive alcohol
8)Subjects who smoke daily
9)Subjects who had taken antibiotics and/or anti-microbe a gents within 1 month prior to date of the informed consent, or who is going to taking them during study
10)Subjects who taking medicine that may affect the examination and subjects who eat daily brown rice, cereals etc
11)Subjects who take health food (a probiotic dairy product etc) excessively that may affect the examination
12)Subjects who is allergic to rice
13)Subjects who are pregnant or breast-feeding, or subjects who expect to be pregnant during this study
14)Subjects who participating in other clinical studies, or who are planning to participate in other clinical studies during the present study
15)Subjects whose fasting breath methane concentration is 10 ppm or above at the screening test
16)Subjects who are judged as unsuitable for the study by the investigator for other reasons

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Kei
Middle name
Last name Yui

Organization

FANCL Corporation

Division name

Research Institute, Health science research center

Zip code

244-0806

Address

12-13, Kamishinano, Totsuka-ku, Yokohama, Kanagawa

TEL

045-820-3755

Email

ke-yui@fancl.co.jp


Public contact

Name of contact person

1st name Eiji
Middle name
Last name Yoshikawa

Organization

KSO Corporation

Division name

Sales department

Zip code

105-0023

Address

Shibaura Omodaka Building7F, 1-9-7 Shibaura, Minato-ku, Tokyo

TEL

03-3452-7733

Homepage URL


Email

yoshikawa@kso.co.jp


Sponsor or person

Institute

KSO Corporation

Institute

Department

Personal name



Funding Source

Organization

FANCL Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of Nihonbashi Cardiology Clinic

Address

Kyodo Bldg. #201, 13 - 4 Nihonbashi Kodenmacho, Chuo-ku, Tokyo

Tel

03-5641-4133

Email

niho-jimucho@well-sleep.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本橋循環器科クリニック(東京都) Nihonbashi Cardiology Clinic(Tokyo)


Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 02 Month 08 Day

Date of IRB

2019 Year 02 Month 08 Day

Anticipated trial start date

2019 Year 02 Month 17 Day

Last follow-up date

2019 Year 03 Month 17 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 02 Month 15 Day

Last modified on

2019 Year 08 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040881


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name